Patients and visitors

Department of Modern Immunotherapy Research

The main goal of our research is the development of new medical products of active cell immunotherapy with the aim of improving the treatment of hemato-oncological diseases. We focus on the use of cells with natural cytotoxic activity against neoplastic cells, mainly NK cells, gamma-delta

T lymphocytes, NK-T cells or cytokine-induced killer cells. The development of new protocols for cellular immunotherapy is closely connected to the research of basic properties and mechanisms controlling the differentiation and activation of antineoplastic cytotoxic functions of cells. Our research strives for acquiring new information about molecular control of the development of cytotoxic properties of cells, their heterogeneity and about possibilities of phenotype manipulations that can be used in immunotherapy. At the same time, we have been developing new experimental methods for cytotoxicity analysis that will contribute to the selection and validation of the best prospective medicinal products. The main goal is to use the results of our research to optimize the conditions for a maximum expansion of cells and their cytotoxic activity and for preserving cytotoxic capabilities of cell also after their transfer into patients’ blood stream.

Quick contact

Outpatient Department
+420 221 977 315

Inpatient Department
+420 221 977 226

Intensive Care Unit (ICU)
+420 221 977 294

Transplant Unit
+420 221 977 229

Opening hours

Outpatient Department
Mo – Fr: 07:00–18:00
Weekends: 09:00–13:00

Inpatient Department
Mo – Fr: 13:00–18:00

ICU and Transplant Unit
Mo – Fr: 13:00–18:00

How to find us


Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

Building B

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here